Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145

Carcinogenesis

Volumn 25, Issue 8, 2004, Pages 1359-1370

  Trzeciak, Andrzej R ^a   Nyaga, Simon G ^a   Jaruga, Pawel ^b,c   Lohani, Althaf ^a   Dizdaroglu, Miral ^c   Evans, Michele K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; CATALASE; DNA; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; 5 HYDROXYCYTOSINE; 5-HYDROXYCYTOSINE; 8 HYDROXYADENINE; 8-HYDROXYADENINE; 8-HYDROXYGUANINE; ADENINE; ANTIOXIDANT; CYTOCHROME C OXIDASE; CYTOSINE; DRUG DERIVATIVE; GUANINE; OXYGEN;

ADULT; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MITOCHONDRION; ONCOGENE; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION EXPOSURE; CELL DIVISION; CELL NUCLEUS; CHEMISTRY; COMET ASSAY; DOSE RESPONSE; GENETICS; KINETICS; MASS FRAGMENTOGRAPHY; METABOLISM; PROSTATE TUMOR; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ADENINE; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; COMET ASSAY; CYTOSINE; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX IV; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUTATHIONE PEROXIDASE; GUANINE; HUMANS; KINETICS; MALE; MITOCHONDRIA; OXYGEN; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 4344647877     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh144     Document Type: Article

References (91)

1. Jemal,A., Thomas,A., Murray,T. and Thun,M. (2002) Cancer statistics, 2002. CA Cancer J. Clin., 52, 23-47.
2. Hsing,A.W., Tsao,L. and Devesa,S.S. (2000) International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer, 85, 60-67.
3. Nelson,W.G., De Marzo,A.M. and Isaacs,W.B. (2003) Prostate cancer. N. Engl. J. Med., 349, 366-381.
4. Millar,D.S., Ow,K.K., Paul,C.L., Russell,P.J., Molloy,P.L. and Clark,S.J. (1999) Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene, 18, 1313-1324.
5. Lee,W.H., Morton,R.A., Epstein,J.I., Brooks,J.D., Campbell,P.A., Bova,G.S., Hsieh,W.S., Isaacs,W.B. and Nelson,W.G. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl Acad. Sci. USA, 91, 11733-11737.
6. Lin,X., Tascilar,M., Lee,W.H. et al. (2001) GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol., 159, 1815-1826.
7. Kinzler,K.W. and Vogelstein,B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761-763.
8. Nelson,C.P., Kidd,L.C., Sauvageot,J., Isaacs,W.B., De Marzo,A.M., Groopman,J.D., Nelson,W.G. and Kensler,T.W. (2001) Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res., 61, 103-109.
9. Stuart,G.R., Holcroft,J., de Boer,J.G. and Glickman,B.W. (2000) Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res., 60, 266-268.
10. Shirai,J., Sano,M., Tamano,S. et al. (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res., 57, 195-198.
11. Ames,B.N., Shigenaga,M.K. and Hagen,T.M. (1993) Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA, 90, 7915-7922.
12. Malins,D.C., Johnson,P.M., Wheeler,T.M., Barker,E.A., Polissar,N.L. and Vinson,M.A. (2001) Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res., 61, 6025-6028.
13. De Marzo,A.M., Coffey,D.S. and Nelson,W.G. (1999) New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology, 53, 29-42.
14. De Marzo,A.M., Putzi,M.J. and Nelson,W.G. (2001) New concepts in the pathology of prostatic epithelial carcinogenesis. Urology, 57, 103-114.
15. Bostwick,D.G., Alexander,E.E., Singh,R. et al. (2000) Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer, 89, 123-134.
16. Olinski,R., Zastawny,T.H., Foksinski,M., Barecki,A. and Dizdaroglu,M. (1995) DNA base modifications and antioxidant enzyme activities in human benign prostatic hyperplasia. Free Radic. Biol. Med., 18, 807-813.
17. Malins,D.C., Johnson,P.M., Barker,E.A., Polissar,N.L., Wheeler,T.M. and Anderson,K.M. (2003) Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proc. Natl Acad. Sci. USA, 100, 5401-5406.
18. Xu,J., Zheng,S.L., Turner,A. et al. (2002) Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res., 62, 2253-2257.
19. Richter,C., Park,J.W. and Ames,B.N. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl Acad. Sci. USA, 85, 6465-6467.
20. Dizdaroglu,M. (1991) Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med., 10, 225-242.
21. Ide,H., Kow,Y.W. and Wallace,S.S. (1985) Thymine glycols and urea residues in M13 DNA constitute replicative blocks in vitro. Nucleic Acids Res., 13, 8035-8052.
22. Hatahet,Z., Purmal,A.A. and Wallace,S.S. (1994) Oxidative DNA lesions as blocks to in vitro transcription by phage T7 RNA polymerase. Ann. N. Y. Acad. Sci., 726, 346-348.
23. Grollman,A.P. and Moriya,M. (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet., 9, 246-249.
24. Kamiya,H., Miura,H., Murata-Kamiya,N. et al. (1995) 8-Hydroxyadenine (7,8-dihydro-8-oxoadenine) induces misincorporation in in vitro DNA synthesis and mutations in NIH 3T3 cells. Nucleic Acids Res., 23, 2893-2899.
25. Gunther,T., Schneider-Stock,R., Rys,J., Niezabitowski,A. and Roessner,A. (1997) p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. J. Cancer Res. Clin. Oncol., 123, 388-394.
26. Hollstein,M., Shomer,B., Greenblatt,M., Soussi,T., Hovig,E., Montesano,R. and Harris,C.C. (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146.
27. Smith,M.L. and Seo,Y.R. (2002) p53 regulation of DNA excision repair pathways. Mutagenesis, 17, 149-156.
28. Jackson,A.L. and Loeb,L.A. (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res., 477, 7-21.
29. Mitra,S., Izumi,T., Boldogh,I., Bhakat,K.K., Hill,J.W. and Hazra,T.K. (2002) Choreography of oxidative damage repair in mammalian genomes. Free Radic. Biol. Med., 33, 15-28.
30. Cooke,M.S., Evans,M.D., Dizdaroglu,M. and Lunec,J. (2003) Oxidative DNA damage: mechanisms, mutation and disease. FASEB J., 17, 1195-1214.
31. Mambo,E., Nyaga,S.G., Bohr,V.A. and Evans,M.K. (2002) Defective repair of 8-hydroxyguanine in mitochondria of MCF-7 and MDA-MB-468 human breast cancer cell lines. Cancer Res., 62, 1349-1355.
32. Bogliolo,M., Taylor,R.M., Caldecott,K.W. and Frosina,G. (2000) Reduced ligation during DNA base excision repair supported by BRCA2 mutant cells. Oncogene, 19, 5781-5787.
33. Strom,S.S., Spitz,M.R., Yamamura,Y., Babaian,R.J., Scardino,P.T. and Wei,Q. (2001) Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. Prostate, 47, 269-275.
34. Yeh,C.C., Lee,C. and Dahiya,R. (2001) DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem. Biophys. Res. Commun., 285, 409-413.
35. Chen,Y., Wang,J., Fraig,M.M., Metcalf,J., Turner,W.R., Bissada,N.K., Watson,D.K. and Schweinfest,C.W. (2001) Defects of DNA mismatch repair in human prostate cancer. Cancer Res., 61, 4112-4121.
36. Leach,F.S., Velasco,A., Hsieh,J.T., Sagalowsky,A.I. and McConnell,J.D. (2000) The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP. J. Urol., 164, 1830-1833.
37. Bello,D., Webber,M.M., Kleinman,H.K., Wartinger,D.D. and Rhim,J.S. (1997) Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis, 18, 1215-1223.
38. Singh,N.P., McCoy,M.T., Tice,R.R. and Schneider,E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
39. Collins,A.R., Dobson,V.L., Dusinska,M., Kennedy,G. and Stetina,R. (1997) The comet assay: what can it really tell us? Mutat. Res., 375, 183-193.
40. Olive,P.L., Banath,J.P. and Durand,R.E. (1990) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the 'comet' assay. Radiat. Res., 122, 86-94.
41. Miller,S.A., Dykes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
42. Dizdaroglu,M., Jaruga,P. and Rodriguez,H. (2001) Measurement of 8-hydroxy-2′-deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res., 29, E12.
43. Tuo,J., Jaruga,P., Rodriguez,H., Dizdaroglu,M. and Bohr,V.A. (2002) The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA. J. Biol. Chem., 277, 30832-30837.
44. Dizdaroglu,M., Bauche,C., Rodriguez,H. and Laval,J. (2000) Novel substrates of Escherichia coli nth protein and its kinetics for excision of modified bases from DNA damaged by free radicals. Biochemistry, 39, 5586-5592.
45. Nyaga,S.G. and Bohr,V.A. (2002) Characterization of specialized mtDNA glycosylases. Methods Mol. Biol., 197, 227-244.
46. Manley,J.L., Fire,A., Cano,A., Sharp,P.A. and Gefter,M.L. (1980) DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc. Natl Acad. Sci. USA, 77, 3855-3859.
47. Oberley,T.D., Zhong,W., Szweda,L.I. and Oberley,L.W. (2000) Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate, 44, 144-155.
48. Hazra,T.K., Kow,Y.W., Hatahet,Z., Imhoff,B., Boldogh,I., Mokkapati,S.K., Mitra,S. and Izumi,T. (2002) Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J. Biol. Chem., 277, 30417-30420.
49. Hazra,T.K., Izumi,T., Boldogh,I., Imhoff,B., Kow,Y.W., Jaruga,P., Dizdaroglu,M. and Mitra,S. (2002) Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc. Natl Acad. Sci. USA, 99, 3523-3528.
50. Hill,J.W., Hazra,T.K., Izumi,T. and Mitra,S. (2001) Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair. Nucleic Acids Res., 29, 430-438.
51. Marenstein,D.R., Chan,M.K., Altamirano,A., Basu,A.K., Boorstein,R.J., Cunningham,R.P. and Teebor,G.W. (2003) Substrate specificity of human endonuclease III (hNTH1). Effect of human APE1 on hNTH1 activity. J. Biol. Chem., 278, 9005-9012.
52. Vidal,A.E., Hickson,I.D., Boiteux,S. and Radicella,J.P. (2001) Mechanism of stimulation of the DNA glycosylase activity of hOGG1 by the major human AP endonuclease: bypass of the AP lyase activity step. Nucleic Acids Res., 29, 1285-1292.
53. Kelley,M.R., Cheng,L., Foster,R., Tritt,R., Jiang,J., Broshears,J. and Koch,M. (2001) Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin. Cancer Res., 7, 824-830.
54. Gros,L., Saparbaev,M.K. and Laval,J. (2002) Enzymology of the repair of free radicals-induced DNA damage. Oncogene, 21, 8905-8925.
55. Krokan,H.E., Nilsen,H., Skorpen,F., Otterlei,M. and Slupphaug,G. (2000) Base excision repair of DNA in mammalian cells. FEBS Lett., 476, 73-77.
56. Bjoras,M., Seeberg,E., Luna,L., Pearl,L.H. and Barrett,T.E. (2002) Reciprocal 'flipping' underlies substrate recognition and catalytic activation by the human 8-oxo-guanine DNA glycosylase. J. Mol. Biol., 317, 171-177.
57. Bjoras,M., Luna,L., Johnsen,B., Hoff,E., Haug,T., Rognes,T. and Seeberg,E. (1997) Opposite base-dependent reactions of a human base excision repair enzyme on DNA containing 7,8-dihydro-8-oxoguanine and abasic sites. EMBO J, 16, 6314-6322.
58. Marenstein,D.R., Ocampo,M.T., Chan,M.K., Altamirano,A., Basu,A.K., Boorstein,R.J., Cunningham,R.P. and Teebor,G.W. (2001) Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J. Biol. Chem., 276, 21242-21249.
59. Minowa,O., Arai,T., Hirano,M. et al. (2000) Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc. Natl Acad. Sci. USA, 97, 4156-4161.
60. Klungland,A., Rosewell,I., Hollenbach,S., Larsen,E., Daly,G., Epe,B., Seeberg,E., Lindahl,T. and Barnes,D.E. (1999) Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl Acad. Sci. USA, 96, 13300-13305.
61. Takao,M., Kanno,S., Shiromoto,T. et al. (2002) Novel nuclear and mitochondrial glycosylases revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog for repair of thymine glycols. EMBO J., 21, 3486-3493.
62. Takao,M., Kanno,S., Kobayashi,K., Zhang,Q.M., Yonei,S., van der Horst,G.T. and Yasui,A. (2002) A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue. J. Biol. Chem., 277, 42205-42213.
63. de Souza-Pinto,N.C., Eide,L., Hogue,B.A., Thybo,T., Stevnsner,T., Seeberg,E., Klungland,A. and Bohr,V.A. (2001) Repair of 8-oxodeoxyguanosine lesions in mitochondrial DNA depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res., 61, 5378-5381.
64. Audebert,M., Chevillard,S., Levalois,C. et al. (2000) Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res., 60, 4740-4744.
65. Audebert,M., Charbonnier,J.B., Boiteux,S. and Radicella,J.P. (2002) Mitochondrial targeting of human 8-oxoguanine DNA glycosylase hOGG1 is impaired by a somatic mutation found in kidney cancer. DNA Rep., 1, 497-505.
66. Ikeda,S., Kohmoto,T., Tabata,R. and Seki,Y. (2002) Differential intracellular localization of the human and mouse endonuclease III homologs and analysis of the sorting signals. DNA Rep., 1, 847-854.
67. de Boer,J.G. (2002) Polymorphisms in DNA repair and environmental interactions. Mutat. Res., 509, 201-210.
68. Hu,J.J., Mohrenweiser,H.W., Bell,D.A., Leadon,S.A. and Miller,M.S. (2002) Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol. Appl. Pharmacol., 185, 64-73.
69. Goode,E.L., Ulrich,C.M. and Potter,J.D. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1513-1530.
70. Le Marchand,L., Donlon,T., Lum-Jones,A., Seifried,A. and Wilkens,L.R. (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 409-412.
71. Elahi,A., Zheng,Z., Park,J., Eyring,K., McCaffrey,T. and Lazarus,P. (2002) The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis, 23, 1229-1234.
72. Tarng,D.C., Tsai,T.J., Chen,W.T., Liu,T.Y. and Wei,Y.H. (2001) Effect of human OGG1 1245C → G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J. Am. Soc. Nephrol., 12, 2338-2347.
73. Dherin,C., Radicella,J.P., Dizdaroglu,M. and Boiteux,S. (1999) Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1 (Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res., 27, 4001-4007.
74. Dantzer,F., Luna,L., Bjoras,M. and Seeberg,E. (2002) Human OGG1 undergoes serine phosphorylation and associates with the nuclear matrix and mitotic chromatin in vivo. Nucleic Acids Res., 30, 2349-2357.
75. Gu,Y. and Lu,A.L. (2001) Differential DNA recognition and glycosylase activity of the native human MutY homolog (hMYH) and recombinant hMYH expressed in bacteria. Nucleic Acids Res., 29, 2666-2674.
76. Tini,M., Benecke,A., Um,S.J., Torchia,J., Evans,R.M. and Chambon,P. (2002) Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol. Cell, 9, 265-277.
77. Hsieh,M.M., Hegde,V., Kelley,M.R. and Deutsch,W.A. (2001) Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation. Nucleic Acids Res., 29, 3116-3122.
78. Hasan,S., El-Andaloussi,N., Hardeland,U., Hassa,P.O., Burki,C., Imhof,R., Schar,P. and Hottiger,M.O. (2002) Acetylation regulates the DNA end-trimming activity of DNA polymerase beta. Mol. Cell, 10, 1213-1222.
79. Hasan,S., Stucki,M., Hassa,P.O., Imhof,R., Gehrig,P., Hunziker,P., Hubscher,U. and Hottiger,M.O. (2001) Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300. Mol. Cell, 7, 1221-1231.
80. Carroll,A.G., Voeller,H.J., Sugars,L. and Gelmann,E.P. (1993) p53 oncogene mutations in three human prostate cancer cell lines. Prostate, 23, 123-134.
81. Sasaki,R., Shirakawa,T., Zhang,Z.J., Tamekane,A., Matsumoto,A., Sugimura,K., Matsuo,M., Kamidono,S. and Gotoh,A. (2001) Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 51, 1336-1345.
82. Offer,H., Milyavsky,M., Erez,N., Matas,D., Zurer,I., Harris,C.C. and Rotter,V. (2001) Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene, 20, 581-589.
83. Zhou,J., Ahn,J., Wilson,S.H. and Prives,C. (2001) A role for p53 in base excision repair. EMBO J., 20, 914-923.
84. Seo,Y.R., Fishel,M.L., Amundson,S., Kelley,M.R. and Smith,M.L. (2002) Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene, 21, 731-737.
85. Seo,Y.R., Kelley,M.R. and Smith,M.L. (2002) Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl Acad. Sci. USA, 99, 14548-14553.
86. Jung,K., Seidel,B., Rudolph,B., Lein,M., Cronauer,M.V., Henke,W., Hampel,G., Schnorr,D. and Loening,S.A. (1997) Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic. Biol. Med., 23, 127-133.
87. Li,N., Oberley,T.D., Oberley,L.W. and Zhong,W. (1998) Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate, 35, 221-233.
88. Keyer,K. and Imlay,J.A. (1996) Superoxide accelerates DNA damage by elevating free-iron levels. Proc. Natl Acad. Sci. USA, 93, 13635-13640.
89. Klein,E.A. (2004) Selenium: epidemiology and basic science. J. Urol., 171, S50-S53.
90. Barqawi,A., Thompson,I.M. and Crawford,E.D. (2004) Prostate cancer chemoprevention: an overview of United States trials. J. Urol., 171, S5-9.
91. Leach,R., Pollock,B., Basler,J., Troyer,D., Naylor,S. and Thompson,I.M. (2003) Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials. Urol. Clin. North Am., 30, 227-237.